The Cell & Gene Meeting on the Mediterranean 2021 is being held virtually this year. Mike Lehmicke, Director of Science & Industry Affairs, Alliance for Regenerative Medicine (ARM), Washington, D.C., shares his thoughts on the benefits of the virtual format, as well as some of the key sessions to look out for. The conference will feature panel discussions dedicated to the development of advanced therapy medicinal products (ATMPs) for specific indications, including in neurological and ophthalmologic diseases, as well a session on next generation applications of induced pluripotent stem cell (iPSC) technologies. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.